Kevin Nee, MD, PhD

All Publications

• Colorectal Cancer Stem Cell Subtypes Orchestrate Distinct Tumor Microenvironments. bioRxiv : the preprint server for biology Hosohama, L., Tifrea, D. F., Nee, K., Park, S. Y., Wu, J., Habowski, A. N., Van, C., Seldin, M. M., Edwards, R. A., Waterman, M. L. 2024

  Abstract

  Several classification systems have been developed to define tumor subtypes in colorectal cancer (CRC). One system proposes that tumor heterogeneity derives in part from distinct cancer stem cell populations that co-exist as admixtures of varying proportions. However, the lack of single cell resolution has prohibited a definitive identification of these types of stem cells and therefore any understanding of how each influence tumor phenotypes. Here were report the isolation and characterization of two cancer stem cell subtypes from the SW480 CRC cell line. We find these cancer stem cells are oncogenic versions of the normal Crypt Base Columnar (CBC) and Regenerative Stem Cell (RSC) populations from intestinal crypts and that their gene signatures are consistent with the "Admixture" and other CRC classification systems. Using publicly available single cell RNA sequencing (scRNAseq) data from CRC patients, we determine that RSC and CBC cancer stem cells are commonly co-present in human CRC. To characterize influences on the tumor microenvironment, we develop subtype-specific xenograft models and we define their tumor microenvironments at high resolution via scRNAseq. RSCs create differentiated, inflammatory, slow growing tumors. CBCs create proliferative, undifferentiated, invasive tumors. With this enhanced resolution, we unify current CRC patient classification schema with TME phenotypes and organization.

  View details for DOI 10.1101/2024.04.25.591144

  View details for PubMedID 38712298

  View details for PubMedCentralID PMC11071458

• Targeting tumor-stromal interactions in triple-negative breast cancer using a human vascularized micro-tumor model. Breast cancer research : BCR Hachey, S. J., Hatch, C. J., Gaebler, D., Mocherla, A., Nee, K., Kessenbrock, K., Hughes, C. C. 2024; 26 (1): 5

  Abstract

  Triple-negative breast cancer (TNBC) is highly aggressive with limited available treatments. Stromal cells in the tumor microenvironment (TME) are crucial in TNBC progression; however, understanding the molecular basis of stromal cell activation and tumor-stromal crosstalk in TNBC is limited. To investigate therapeutic targets in the TNBC stromal niche, we used an advanced human in vitro microphysiological system called the vascularized micro-tumor (VMT). Using single-cell RNA sequencing, we revealed that normal breast tissue stromal cells activate neoplastic signaling pathways in the TNBC TME. By comparing interactions in VMTs with clinical data, we identified therapeutic targets at the tumor-stromal interface with potential clinical significance. Combining treatments targeting Tie2 signaling with paclitaxel resulted in vessel normalization and increased efficacy of paclitaxel in the TNBC VMT. Dual inhibition of HER3 and Akt also showed efficacy against TNBC. These data demonstrate the potential of inducing a favorable TME as a targeted therapeutic approach in TNBC.

  View details for DOI 10.1186/s13058-023-01760-y

  View details for PubMedID 38183074

  View details for PubMedCentralID PMC10768273

• A spatially resolved single-cell genomic atlas of the adult human breast. Nature Kumar, T., Nee, K., Wei, R., He, S., Nguyen, Q. H., Bai, S., Blake, K., Pein, M., Gong, Y., Sei, E., Hu, M., Casasent, A. K., Thennavan, A., Li, J., Tran, T., Chen, K., Nilges, B., Kashikar, N., Braubach, O., Ben Cheikh, B., Nikulina, N., Chen, H., Teshome, M., Menegaz, B., Javaid, H., Nagi, C., Montalvan, J., Lev, T., Mallya, S., Tifrea, D. F., Edwards, R., Lin, E., Parajuli, R., Hanson, S., Winocour, S., Thompson, A., Lim, B., Lawson, D. A., Kessenbrock, K., Navin, N. 2023; 620 (7972): 181-191

  Abstract

  The adult human breast is comprised of an intricate network of epithelial ducts and lobules that are embedded in connective and adipose tissue1-3. Although most previous studies have focused on the breast epithelial system4-6, many of the non-epithelial cell types remain understudied. Here we constructed the comprehensive Human Breast Cell Atlas (HBCA) at single-cell and spatial resolution. Our single-cell transcriptomics study profiled 714,331 cells from 126 women, and 117,346 nuclei from 20 women, identifying 12 major cell types and 58 biological cell states. These data reveal abundant perivascular, endothelial and immune cell populations, and highly diverse luminal epithelial cell states. Spatial mapping using four different technologies revealed an unexpectedly rich ecosystem of tissue-resident immune cells, as well as distinct molecular differences between ductal and lobular regions. Collectively, these data provide a reference of the adult normal breast tissue for studying mammary biology and diseases such as breast cancer.

  View details for DOI 10.1038/s41586-023-06252-9

  View details for PubMedID 37380767

  View details for PubMedCentralID 5966421

• Preneoplastic stromal cells promote BRCA1-mediated breast tumorigenesis NATURE GENETICS Nee, K., Ma, D., Nguyen, Q. H., Pein, M., Pervolarakis, N., Insua-Rodriguez, J., Gong, Y., Hernandez, G., Alshetaiwi, H., Williams, J., Rauf, M., Dave, K., Boyapati, K., Hasnain, A., Calderon, C., Markaryan, A., Edwards, R., Lin, E., Parajuli, R., Zhou, P., Nie, Q., Shalabi, S., LaBarge, M. A., Kessenbrock, K. 2023: 595-606

  Abstract

  Women with germline BRCA1 mutations (BRCA1+/mut) have increased risk for hereditary breast cancer. Cancer initiation in BRCA1+/mut is associated with premalignant changes in breast epithelium; however, the role of the epithelium-associated stromal niche during BRCA1-driven tumor initiation remains unclear. Here we show that the premalignant stromal niche promotes epithelial proliferation and mutant BRCA1-driven tumorigenesis in trans. Using single-cell RNA sequencing analysis of human preneoplastic BRCA1+/mut and noncarrier breast tissues, we show distinct changes in epithelial homeostasis including increased proliferation and expansion of basal-luminal intermediate progenitor cells. Additionally, BRCA1+/mut stromal cells show increased expression of pro-proliferative paracrine signals. In particular, we identify pre-cancer-associated fibroblasts (pre-CAFs) that produce protumorigenic factors including matrix metalloproteinase 3 (MMP3), which promotes BRCA1-driven tumorigenesis in vivo. Together, our findings demonstrate that precancerous stroma in BRCA1+/mut may elevate breast cancer risk through the promotion of epithelial proliferation and an accumulation of luminal progenitor cells with altered differentiation.

  View details for DOI 10.1038/s41588-023-01298-x

  View details for Web of Science ID 000948843800003

  View details for PubMedID 36914836

  View details for PubMedCentralID 8167363

• An in vitro vascularized micro-tumor model of human colorectal cancer recapitulates in vivo responses to standard-of-care therapy. Lab on a chip Hachey, S. J., Movsesyan, S., Nguyen, Q. H., Burton-Sojo, G., Tankazyan, A., Wu, J., Hoang, T., Zhao, D., Wang, S., Hatch, M. M., Celaya, E., Gomez, S., Chen, G. T., Davis, R. T., Nee, K., Pervolarakis, N., Lawson, D. A., Kessenbrock, K., Lee, A. P., Lowengrub, J., Waterman, M. L., Hughes, C. C. 2021; 21 (7): 1333-1351

  Abstract

  Around 95% of anti-cancer drugs that show promise during preclinical study fail to gain FDA-approval for clinical use. This failure of the preclinical pipeline highlights the need for improved, physiologically-relevant in vitro models that can better serve as reliable drug-screening and disease modeling tools. The vascularized micro-tumor (VMT) is a novel three-dimensional model system (tumor-on-a-chip) that recapitulates the complex human tumor microenvironment, including perfused vasculature, within a transparent microfluidic device, allowing real-time study of drug responses and tumor-stromal interactions. Here we have validated this microphysiological system (MPS) platform for the study of colorectal cancer (CRC), the second leading cause of cancer-related deaths, by showing that gene expression, tumor heterogeneity, and treatment responses in the VMT more closely model CRC tumor clinicopathology than current standard drug screening modalities, including 2-dimensional monolayer culture and 3-dimensional spheroids.

  View details for DOI 10.1039/d0lc01216e

  View details for PubMedID 33605955

  View details for PubMedCentralID PMC8525497

• Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics. Science immunology Alshetaiwi, H., Pervolarakis, N., McIntyre, L. L., Ma, D., Nguyen, Q., Rath, J. A., Nee, K., Hernandez, G., Evans, K., Torosian, L., Silva, A., Walsh, C., Kessenbrock, K. 2020; 5 (44)

  Abstract

  Myeloid-derived suppressor cells (MDSCs) are innate immune cells that acquire the capacity to suppress adaptive immune responses during cancer. It remains elusive how MDSCs differ from their normal myeloid counterparts, which limits our ability to specifically detect and therapeutically target MDSCs during cancer. Here, we sought to determine the molecular features of breast cancer-associated MDSCs using the widely studied mouse model based on the mouse mammary tumor virus (MMTV) promoter-driven expression of the polyomavirus middle T oncoprotein (MMTV-PyMT). To identify MDSCs in an unbiased manner, we used single-cell RNA sequencing to compare MDSC-containing splenic myeloid cells from breast tumor-bearing mice with wild-type controls. Our computational analysis of 14,646 single-cell transcriptomes revealed that MDSCs emerge through an aberrant neutrophil maturation trajectory in the spleen that confers them an immunosuppressive cell state. We establish the MDSC-specific gene signature and identify CD84 as a surface marker for improved detection and enrichment of MDSCs in breast cancers.

  View details for DOI 10.1126/sciimmunol.aay6017

  View details for PubMedID 32086381

  View details for PubMedCentralID PMC7219211

• Experimental Considerations for Single-Cell RNA Sequencing Approaches. Frontiers in cell and developmental biology Nguyen, Q. H., Pervolarakis, N., Nee, K., Kessenbrock, K. 2018; 6: 108

  Abstract

  Single-cell transcriptomic technologies have emerged as powerful tools to explore cellular heterogeneity at the resolution of individual cells. Previous scientific knowledge in cell biology is largely limited to data generated by bulk profiling methods, which only provide averaged read-outs that generally mask cellular heterogeneity. This averaged approach is particularly problematic when the biological effect of interest is limited to only a subpopulation of cells such as stem/progenitor cells within a given tissue, or immune cell subsets infiltrating a tumor. Great advances in single-cell RNA sequencing (scRNAseq) enabled scientists to overcome this limitation and allow for in depth interrogation of previously unexplored rare cell types. Due to the high sensitivity of scRNAseq, adequate attention must be put into experimental setup and execution. Careful handling and processing of cells for scRNAseq is critical to preserve the native expression profile that will ensure meaningful analysis and conclusions. Here, we delineate the individual steps of a typical single-cell analysis workflow from tissue procurement, cell preparation, to platform selection and data analysis, and we discuss critical challenges in each of these steps, which will serve as a helpful guide to navigate the complex field of single-cell sequencing.

  View details for DOI 10.3389/fcell.2018.00108

  View details for PubMedID 30234113

  View details for PubMedCentralID PMC6131190

• PGC Reversion to Pluripotency Involves Erasure of DNA Methylation from Imprinting Control Centers followed by Locus-Specific Re-methylation. Stem cell reports Oliveros-Etter, M., Li, Z., Nee, K., Hosohama, L., Hargan-Calvopina, J., Lee, S. A., Joti, P., Yu, J., Clark, A. T. 2015; 5 (3): 337-49

  Abstract

  Primordial germ cells (PGCs) are fate restricted to differentiate into gametes in vivo. However, when removed from their embryonic niche, PGCs undergo reversion to pluripotent embryonic germ cells (EGCs) in vitro. One of the major differences between EGCs and embryonic stem cells (ESCs) is variable methylation at imprinting control centers (ICCs), a phenomenon that is poorly understood. Here we show that reverting PGCs to EGCs involved stable ICC methylation erasure at Snrpn, Igf2r, and Kcnqot1. In contrast, the H19/Igf2 ICC undergoes erasure followed by de novo re-methylation. PGCs differentiated in vitro from ESCs completed Snrpn ICC erasure. However, the hypomethylated state is highly unstable. We also discovered that when the H19/Igf2 ICC was abnormally hypermethylated in ESCs, this is not erased in PGCs differentiated from ESCs. Therefore, launching PGC differentiation from ESC lines with appropriately methylated ICCs is critical to the generation of germline cells that recapitulate endogenous ICC erasure.

  View details for DOI 10.1016/j.stemcr.2015.07.006

  View details for PubMedID 26278040

  View details for PubMedCentralID PMC4618453

• The Aorta-Gonad-Mesonephros Organ Culture Recapitulates 5hmC Reorganization and Replication-Dependent and Independent Loss of DNA Methylation in the Germline. Stem cells and development Calvopina, J. H., Cook, H., Vincent, J. J., Nee, K., Clark, A. T. 2015; 24 (13): 1536-45

  Abstract

  Removal of cytosine methylation from the genome is critical for reprogramming and transdifferentiation and plays a central role in our understanding of the fundamental principles of embryo lineage development. One of the major models for studying cytosine demethylation is the mammalian germ line during the primordial germ cell (PGC) stage of embryo development. It is now understood that oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) is required to remove cytosine methylation in a locus-specific manner in PGCs; however, the mechanisms downstream of 5hmC are controversial and hypothesized to involve either active demethylation or replication-coupled loss. In the current study, we used the aorta-gonad-mesonephros (AGM) organ culture model to show that this model recapitulates germ line reprogramming, including 5hmC reorganization and loss of cytosine methylation from Snrpn and H19 imprinting control centers (ICCs). To directly address the hypothesis that cell proliferation is required for cytosine demethylation, we blocked PI3-kinase-dependent PGC proliferation and show that this leads to a G1 and G2/M cell cycle arrest in PGCs, together with retained levels of cytosine methylation at the Snrpn ICC, but not at the H19 ICC. Taken together, the AGM organ culture model is an important tool to evaluate mechanisms of locus-specific demethylation and the role of PI3-kinase-dependent PGC proliferation in the locus-specific removal of cytosine methylation from the genome.

  View details for DOI 10.1089/scd.2014.0410

  View details for PubMedID 25749005

  View details for PubMedCentralID PMC4499782

• In vivo targeting of de novo DNA methylation by histone modifications in yeast and mouse. eLife Morselli, M., Pastor, W. A., Montanini, B., Nee, K., Ferrari, R., Fu, K., Bonora, G., Rubbi, L., Clark, A. T., Ottonello, S., Jacobsen, S. E., Pellegrini, M. 2015; 4: e06205

  Abstract

  Methylation of cytosines (5(me)C) is a widespread heritable DNA modification. During mammalian development, two global demethylation events are followed by waves of de novo DNA methylation. In vivo mechanisms of DNA methylation establishment are largely uncharacterized. Here, we use Saccharomyces cerevisiae as a system lacking DNA methylation to define the chromatin features influencing the activity of the murine DNMT3B. Our data demonstrate that DNMT3B and H3K4 methylation are mutually exclusive and that DNMT3B is co-localized with H3K36 methylated regions. In support of this observation, DNA methylation analysis in yeast strains without Set1 and Set2 shows an increase of relative 5(me)C levels at the transcription start site and a decrease in the gene-body, respectively. We extend our observation to the murine male germline, where H3K4me3 is strongly anti-correlated while H3K36me3 correlates with accelerated DNA methylation. These results show the importance of H3K36 methylation for gene-body DNA methylation in vivo.

  View details for DOI 10.7554/eLife.06205

  View details for PubMedID 25848745

  View details for PubMedCentralID PMC4412109

• The Sm protein methyltransferase PRMT5 is not required for primordial germ cell specification in mice. The EMBO journal Li, Z., Yu, J., Hosohama, L., Nee, K., Gkountela, S., Chaudhari, S., Cass, A. A., Xiao, X., Clark, A. T. 2015; 34 (6): 748-58

  Abstract

  PRMT5 is a type II protein arginine methyltransferase with roles in stem cell biology, reprograming, cancer and neurogenesis. During embryogenesis in the mouse, it was hypothesized that PRMT5 functions with the master germline determinant BLIMP1 to promote primordial germ cell (PGC) specification. Using a Blimp1-Cre germline conditional knockout, we discovered that Prmt5 has no major role in murine germline specification, or the first global epigenetic reprograming event involving depletion of cytosine methylation from DNA and histone H3 lysine 9 dimethylation from chromatin. Instead, we discovered that PRMT5 functions at the conclusion of PGC reprograming I to promote proliferation, survival and expression of the gonadal germline program as marked by MVH. We show that PRMT5 regulates gene expression by promoting methylation of the Sm spliceosomal proteins and significantly altering the spliced repertoire of RNAs in mammalian embryonic cells and primordial cells.

  View details for DOI 10.15252/embj.201489319

  View details for PubMedID 25519955

  View details for PubMedCentralID PMC4369312

• MORC1 represses transposable elements in the mouse male germline. Nature communications Pastor, W. A., Stroud, H., Nee, K., Liu, W., Pezic, D., Manakov, S., Lee, S. A., Moissiard, G., Zamudio, N., Bourc'his, D., Aravin, A. A., Clark, A. T., Jacobsen, S. E. 2014; 5: 5795

  Abstract

  The Microrchidia (Morc) family of GHKL ATPases are present in a wide variety of prokaryotic and eukaryotic organisms but are of largely unknown function. Genetic screens in Arabidopsis thaliana have identified Morc genes as important repressors of transposons and other DNA-methylated and silent genes. MORC1-deficient mice were previously found to display male-specific germ cell loss and infertility. Here we show that MORC1 is responsible for transposon repression in the male germline in a pattern that is similar to that observed for germ cells deficient for the DNA methyltransferase homologue DNMT3L. Morc1 mutants show highly localized defects in the establishment of DNA methylation at specific classes of transposons, and this is associated with failed transposon silencing at these sites. Our results identify MORC1 as an important new regulator of the epigenetic landscape of male germ cells during the period of global de novo methylation.

  View details for DOI 10.1038/ncomms6795

  View details for PubMedID 25503965

  View details for PubMedCentralID PMC4268658

• Stage-specific roles for tet1 and tet2 in DNA demethylation in primordial germ cells. Cell stem cell Vincent, J. J., Huang, Y., Chen, P. Y., Feng, S., Calvopiña, J. H., Nee, K., Lee, S. A., Le, T., Yoon, A. J., Faull, K., Fan, G., Rao, A., Jacobsen, S. E., Pellegrini, M., Clark, A. T. 2013; 12 (4): 470-8

  Abstract

  Primordial germ cells (PGCs) undergo dramatic rearrangements to their methylome during embryogenesis, including initial genome-wide DNA demethylation that establishes the germline epigenetic ground state. The role of the 5-methylcytosine (5mC) dioxygenases Tet1 and Tet2 in the initial genome-wide DNA demethylation process has not been examined directly. Using PGCs differentiated from either control or Tet2(-/-); Tet1 knockdown embryonic stem cells (ESCs), we show that in vitro PGC (iPGC) formation and genome-wide DNA demethylation are unaffected by the absence of Tet1 and Tet2, and thus 5-hydroxymethylcytosine (5hmC). However, numerous promoters and gene bodies were hypermethylated in mutant iPGCs, which is consistent with a role for 5hmC as an intermediate in locus-specific demethylation. Altogether, our results support a revised model of PGC DNA demethylation in which the first phase of comprehensive 5mC loss does not involve 5hmC. Instead, Tet1 and Tet2 have a locus-specific role in shaping the PGC epigenome during subsequent development.

  View details for DOI 10.1016/j.stem.2013.01.016

  View details for PubMedID 23415914

  View details for PubMedCentralID PMC3684274